Pretreatment With P2Y12 Inhibitors in ST-Segment Elevation Myocardial Infarction-Reference-Cited by-同舟云学术

Pretreatment With P2Y12 Inhibitors in ST-Segment Elevation Myocardial Infarction

Published:2024-01 Issue:1 Volume:17 Page:17-28
ISSN:1936-8798
Container-title:JACC: Cardiovascular Interventions
language:en
Short-container-title:JACC: Cardiovascular Interventions

Author:

Rohla Miklos^ORCID,Ye Shirley Xinyu,Shibutani Hiroki,Bruno Jolie,Otsuka Tatsuhiko,Häner Jonas D.,Bär Sarah,Temperli Fabrice,Kavaliauskaite Raminta,Lanz Jonas,Stortecky Stefan^ORCID,Praz Fabien,Hunziker Lukas,Pilgrim Thomas,Siontis George CM.^ORCID,Losdat Sylvain,Windecker Stephan,Räber Lorenz

Publisher

Elsevier BV

Reference35 articles.

1. Pretreatment with P2Y(12) receptor inhibitors in acute coronary syndromes–is the current standpoint of ESC experts sufficiently supported?;Niezgoda;J Clin Med,2023

2. One-year survival after ST-segment-elevation myocardial infarction in relation with prehospital administration of dual antiplatelet therapy;Danchin;Circ Cardiovasc Interv,2018

3. Effect of prehospital treatment in STEMI patients undergoing primary PCI;Fabris;Catheter Cardiovasc Interv,2022

4. Pretreatment with P2Y12 inhibitors in ST-elevation myocardial infarction: a systematic review and meta-analysis;Gewehr;Catheter Cardiovasc Interv,2023

5. No benefit of ticagrelor pretreatment compared with treatment during percutaneous coronary intervention in patients with ST-segment-elevation myocardial infarction undergoing primary percutaneous coronary intervention;Koul;Circ Cardiovasc Interv,2018

Cited by 7 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Antiplatelet Therapy and Anticoagulation before, during, and after Acute Coronary Syndrome;Journal of Clinical Medicine;2024-04-17

2. The Evolving Field of Acute Coronary Syndrome Management: A Critical Appraisal of the 2023 European Society of Cardiology Guidelines for the Management of Acute Coronary Syndrome;Journal of Clinical Medicine;2024-03-25

3. Bending the Reluctance of No Pretreatment With P2Y12 Inhibitors in ST-Segment Elevation Myocardial Infarction;JACC: Cardiovascular Interventions;2024-03

4. Reply;JACC: Cardiovascular Interventions;2024-03

5. Optimizing Antiplatelet Pretreatment in STEMI;JACC: Cardiovascular Interventions;2024-03